Karamedica Inc.
Karamedica has developed a plasma treatment of batch quantities of chitosan and other biopolymers in order to lower endotoxin levels. Karamedica is also currently developing a nanoparticle therapy for cerebral amyloid angiopathy.
Company Location
310 S. Harrington St.
Raleigh
NC
27603
Phone
County
Region
Company Details
Company type
Year founded
2016
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products under development
nanoparticle therapy for cerebral amyloid angiopathy